Author:
Bodin Karl,Ellmerich Stephan,Kahan Melvyn C.,Tennent Glenys A.,Loesch Andrzej,Gilbertson Janet A.,Hutchinson Winston L.,Mangione Palma P.,Gallimore J. Ruth,Millar David J.,Minogue Shane,Dhillon Amar P.,Taylor Graham W.,Bradwell Arthur R.,Petrie Aviva,Gillmore Julian D.,Bellotti Vittorio,Botto Marina,Hawkins Philip N.,Pepys Mark B.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Pepys, M. B. Amyloidosis. Annu. Rev. Med. 57, 223–241 (2006)
2. Pepys, M. B., Dyck, R. F., de Beer, F. C., Skinner, M. & Cohen, A. S. Binding of serum amyloid P component (SAP) by amyloid fibrils. Clin. Exp. Immunol. 38, 284–293 (1979)
3. Pepys, M. B. et al. Amyloid P component. A critical review. Amyloid 4, 274–295 (1997)
4. Pepys, M. B. et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417, 254–259 (2002)
5. Tennent, G. A., Lovat, L. B. & Pepys, M. B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer’s disease and systemic amyloidosis. Proc. Natl Acad. Sci. USA 92, 4299–4303 (1995)
Cited by
286 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献